Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Deals & Financings

Chime Enters Cooperation with Panolos to Develop Multi-Specific Candidate
Tonghua Dongbao Out-Licenses US Rights for Three Insulin Biosimilars to Meitheal
Everest Acquires China Rights to Lupus Nephritis Candidate in $132 Million Agreement
Lynk Closes $16 Million C2 Round to Advance JAK Inhibitors for Autoimmune Diseases
Novartis Ends $2.2 Billion Global PD-1 Partnership with BeiGene
ChinaBio Event
September 20-21 | Shanghai
September 25-26 | Digital
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China